3 Stocks Pushing The Health Care Sector Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 67 points (0.4%) at 16,436 as of Friday, Aug. 8, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,992 issues advancing vs. 961 declining with 169 unchanged.

The Health Care sector currently sits up 0.3% versus the S&P 500, which is up 0.4%. On the negative front, top decliners within the sector include Salix Pharmaceuticals ( SLXP), down 5.4%, Pharmacyclics ( PCYC), down 3.2%, AstraZeneca ( AZN), down 2.8%, Mylan ( MYL), down 1.6% and HCA Holdings ( HCA), down 1.3%. Top gainers within the sector include Air Methods ( AIRM), up 11.3%, Taro Pharmaceutical Industries ( TARO), up 3.6%, Allergan ( AGN), up 2.7%, Valeant Pharmaceuticals International ( VRX), up 1.4% and Humana ( HUM), up 1.1%.

TheStreet would like to highlight 3 stocks pushing the sector lower today:

3. Volcano ( VOLC) is one of the companies pushing the Health Care sector lower today. As of noon trading, Volcano is down $4.04 (-25.6%) to $11.74 on heavy volume. Thus far, 4.3 million shares of Volcano exchanged hands as compared to its average daily volume of 590,500 shares. The stock has ranged in price between $11.54-$13.25 after having opened the day at $13.11 as compared to the previous trading day's close of $15.78.

Volcano Corporation designs, develops, manufactures, and commercializes a suite of precision guided therapy tools primarily to physicians, nurses, and technicians worldwide. The company operates in two segments, Medical and Industrial. Volcano has a market cap of $835.5 million and is part of the health services industry. Shares are down 27.8% year-to-date as of the close of trading on Thursday. Currently there are 6 analysts that rate Volcano a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Volcano as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally high debt management risk, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Volcano Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Select Medical Holdings ( SEM) is down $2.75 (-17.4%) to $13.01 on heavy volume. Thus far, 2.0 million shares of Select Medical Holdings exchanged hands as compared to its average daily volume of 777,000 shares. The stock has ranged in price between $12.58-$15.59 after having opened the day at $15.25 as compared to the previous trading day's close of $15.76.

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals and outpatient rehabilitation clinics in the United States. It operates in two segments, Specialty Hospitals and Outpatient Rehabilitation. Select Medical Holdings has a market cap of $2.1 billion and is part of the health services industry. Shares are up 35.7% year-to-date as of the close of trading on Thursday. Currently there are 3 analysts that rate Select Medical Holdings a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Select Medical Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, attractive valuation levels and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Select Medical Holdings Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Masimo ( MASI) is down $2.91 (-12.0%) to $21.32 on heavy volume. Thus far, 915,210 shares of Masimo exchanged hands as compared to its average daily volume of 583,000 shares. The stock has ranged in price between $19.30-$23.15 after having opened the day at $19.30 as compared to the previous trading day's close of $24.23.

Masimo Corporation, a medical technology company, develops, manufactures, and markets various noninvasive patient monitoring products worldwide. Masimo has a market cap of $1.4 billion and is part of the health services industry. Shares are down 17.1% year-to-date as of the close of trading on Thursday. Currently there are 3 analysts that rate Masimo a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Masimo as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Masimo Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Trump to Blame for Oil's Recent Surge, Not OPEC

Trump to Blame for Oil's Recent Surge, Not OPEC

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

U.S. Earnings On Pace for Best Season in Two Decades but Tech Giants Await

U.S. Earnings On Pace for Best Season in Two Decades but Tech Giants Await

Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning

Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning

Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know

Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know